With the presence of a knowledge-based member of Pardis Technology Park:

First Domestic Medicine for Treatment of Cutaneous Leishmaniasis Unveiled in INOTEX2023

First Domestic Medicine for Treatment of Cutaneous Leishmaniasis Unveiled in INOTEX2023

Share this With Others

Behpad Teb Iranian Company unveiled the first natural-domestic medicine for the treatment of cutaneous leishmaniasis at INOTEX 2023.

In the last day of the INOTEX2023, CEO of Behpad Teb Iranian company unveiled ‘Leish G1’ which is used for treating cutaneous leishmaniasis.

Speaking to reporters, Payendeh said that the company produces drugs and supplements that strengthen the immune system.

We produce drugs that are effective in the treatment of infectious and autoimmune diseases.

COVID19 has shown the role of the immune system and the drugs that are effective in this field to the people in the world, he said adding that the company is doing its best to be effective in the treatment of immune system deficiency diseases.

He noted that the product is also exported to other countries.

Gallery
Comments

Address: Pardis Technology Park, 20th km of Damavand Road (Main Stresst), Tehran I.R. Iran.

Postal Code: 1657163871

Tel: 76250250 _ 021

Fax: 76250100 _ 021

E-mail: info@techpark.ir

website:iiid.tech

Partner Organizations